Related Experiment Video
Updated: Aug 30, 2025
11:00
Single-unit In vivo Recordings from the Optic Chiasm of Rat
Published on: April 2, 2010
11.8K
Ketamine Infusions Administered Solely by Psychiatric Staff
Muaid Ithman1, Robert Sobule2, Carolyn Kundert3
1Vice-Chair at University of Missouri - Columbia School of Medicine Department of Psychiatry (UMC SOM DOP); Associate Professor of Clinical Psychiatry; Medical Director for Interventional Psychiatry; and Associate Medical Director of Missouri University Psychiatric Center, Columbia, Missouri.
Missouri Medicine
|August 29, 2022
Summary
Psychiatric teams can safely administer ketamine infusions for depression treatment. This pilot program at MUPC demonstrates efficacy without anesthesia specialists, offering a new approach for treatment-resistant depression.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Intravenous ketamine shows antidepressant effects for treatment-resistant depression.
- Clinical use is increasing, often involving collaboration between anesthesia and psychiatry.
- No prior reports exist on psychiatric teams solely administering ketamine infusions in hospitals.
Purpose of the Study:
- To investigate the feasibility and safety of ketamine infusions administered by a psychiatric team.
- To explore ketamine as a clinical intervention within a psychiatric hospital setting, independent of anesthesia specialists.
Main Methods:
- A psychiatric-based ketamine infusion team was formed at Missouri University Psychiatric Center (MUPC).
- The team, composed of mental health clinicians and staff, administered ketamine infusions.
- This pilot program focused on clinical application within an acute mental inpatient facility.
Main Results:
- Ketamine infusions were administered by a solely psychiatric-based team.
- The MUPC team demonstrated that ketamine infusions can be a safe and effective intervention.
- This approach was achieved without the need for collaboration with anesthesia specialists.
Conclusions:
- Ketamine infusions can be safely and effectively administered by psychiatric teams in a hospital setting.
- This model provides a novel intervention for treatment-resistant depression.
- Collaboration with anesthesia specialists is not essential for ketamine infusion therapy in this context.
Related Concept Videos
01:24Parenteral Anesthetics: Overview
188
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
188
01:29Drug Delivery: Parenteral Route
769
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
769
01:26Psychosis: Goals of Pharmacotherapy
201
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
201
01:30Electroconvulsive Therapy
130
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
130